Bolligen, Switzerland

Andreas Morell


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovator Highlight: Andreas Morell**

Introduction

Andreas Morell, an accomplished inventor based in Bolligen, Switzerland, has made significant contributions to the field of biotechnology through his innovative work on polypeptides. With three patents to his name, his research focuses on antigen binding structures that can potentially impact pharmaceutical and diagnostic applications.

Latest Patents

One of Andreas Morell's latest patents involves polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens. This remarkable invention details the DNA encoding these polypeptides and outlines the processes for their preparation and use. The resulting polypeptides, known as Fab fragments, are promising candidates for use as active ingredients in therapeutic and diagnostic compositions. Additionally, these Fab fragments and their DNA sequences are instrumental in creating complete recombinant Anti-Rhesus D antibodies, optimizing their utility in medical applications.

Career Highlights

Throughout his career, Andreas has played a key role in two notable companies: ZLB Behring AG and ZLB Bioplasma AG. His tenure at these organizations has allowed him to develop and refine his innovative approaches to life sciences, particularly in the area of antibody development and applications.

Collaborations

Andreas Morell has collaborated with esteemed colleagues such as Martin Imboden and Sylvia Miescher. These professional partnerships have fostered an environment of shared knowledge and have amplified the impact of their collective research efforts.

Conclusion

Andreas Morell exemplifies a dedicated inventor whose work is paving the way for advancements in the biotechnology sector. His patents, particularly in the realm of Rhesus D antigen specificity, underscore the potential for innovation in therapeutic applications. As he continues to contribute to this dynamic field, the outcomes of his work may significantly enhance the landscape of medical treatments and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…